Company / Net Income
Bionano Genomics, Inc. Net Income History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$26.4M
FY2025
5-year range
-$232.5M / -$26.4M
FY2021-FY2025
Trend
+76.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -$232M to -$26M over the past 2 years.
Based on SEC 10-K filings.
-$26M in FY2025.
Improved from -$232M to -$26M over the past 2 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, net income increased 76.4% year-over-year.
- Peak net income was recorded in FY2018.
- Lowest net income in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -8.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$26.4M | +76.4% |
| FY2024 | -$112.0M | +51.8% |
| FY2023 | -$232.5M | -75.3% |
| FY2022 | -$132.6M | -83.1% |
| FY2021 | -$72.4M | -76.2% |
| FY2020 | -$41.1M | -37.9% |
| FY2019 | -$29.8M | -61.2% |
| FY2018 | -$18.5M | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 22, 2026